These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Short- and long-term cyclosporine dosage in liver transplantation. McCaughan GW; Bookallil MJ; Sheil AG Transplant Proc; 1994 Oct; 26(5):2674-5. PubMed ID: 7940837 [No Abstract] [Full Text] [Related]
7. Induction therapy with anti-T-lymphocyte globulin following orthotopic liver transplantation. Schattenfroh N; Lange D; Bechstein WO; Blumhardt G; Keck H; Langrehr JM; Lohmann R; Neuhaus P Transplant Proc; 1993 Aug; 25(4):2702. PubMed ID: 8356722 [No Abstract] [Full Text] [Related]
8. Cyclosporin monotherapy in pancreaticorenal transplantation. Ward RG; Gecim E; Bone JM; Bakran A; Sells RA Transplant Proc; 1994 Apr; 26(2):548. PubMed ID: 8171547 [No Abstract] [Full Text] [Related]
9. Incidence and patterns of rejection using different induction therapies in liver transplant recipients. Elkashab M; Reizig M; Greig PD; Cameron R; Phillips MJ; Chung S; Cattral M; Levy G Transplant Proc; 1994 Oct; 26(5):2669-71. PubMed ID: 7940835 [No Abstract] [Full Text] [Related]
10. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494 [No Abstract] [Full Text] [Related]
11. Renal transplantation in cyclosporine-treated patients over age 50. Riera L; Serón D; Castelao AM; Griñó JM; Franco E; Bover J; Vigués L; Alsina J; Serrallach N Transplant Proc; 1992 Feb; 24(1):122-3. PubMed ID: 1539204 [No Abstract] [Full Text] [Related]
12. Clinical results of quadruple drug immunosuppression in liver transplantation. Fabregat J; Fradera R; Jaurrieta E; Figueras J; Rafecas A; Rufi G; Casanovas T; Casais L; Gil Vernet S Transplant Proc; 1992 Feb; 24(1):148-9. PubMed ID: 1539217 [No Abstract] [Full Text] [Related]
13. Hepatic allograft rejection under quadruple immunosuppressive regimen with cyclosporine A in liver transplantation: incidence of viral and fungal infection. Fabregat J; Fradera R; Figueras J; Rafecas A; Torras J; Martinez LaCasa J; Baliellas C; Casais L; Jaurrieta E Transplant Proc; 1994 Oct; 26(5):2697-9. PubMed ID: 7940845 [No Abstract] [Full Text] [Related]
14. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function. Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289 [No Abstract] [Full Text] [Related]
15. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation. Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233 [No Abstract] [Full Text] [Related]
16. Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group. Abouljoud MS; Levy MF; Klintmalm GB Transplant Proc; 1995 Feb; 27(1):1121-3. PubMed ID: 7533360 [No Abstract] [Full Text] [Related]
17. Long-term nephrotoxicity of low doses of cyclosporine in heart transplant recipients. Ben Hmida M; Baumelou A; Desruesnnes M; Cabrol A; Pavie A; Grandjbakhch I; Cabrol C Transplant Proc; 1995 Oct; 27(5):2725-7. PubMed ID: 7482891 [No Abstract] [Full Text] [Related]
18. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation. McVicar JP; Kowdley KV; Emond MJ; Barr D; Marsh CL; Carithers RL; Perkins JD Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724 [TBL] [Abstract][Full Text] [Related]
19. Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression. McAlister V; Grant D; Roy A; Yilmaz Z; Ghent C; Wall W Transplant Proc; 1993 Feb; 25(1 Pt 2):1400-1. PubMed ID: 8442154 [No Abstract] [Full Text] [Related]
20. Limited utility of early trough cyclosporine level monitoring to predict the rate of acute rejection in the first three months after cardiac transplantation. Jennison SH; Wesp AG; McBride LR; Miller LW Transplant Proc; 1994 Oct; 26(5):2732-5. PubMed ID: 7940857 [No Abstract] [Full Text] [Related] [Next] [New Search]